National Lung Cancer Audit


Annual Reports

Annual Report 2019

Expected to be published August 2020


Spotlight report on curative treatment

Our third spotlight audit was aimed at investigating why the curative intent treatment rates in patients with early-stage lung cancer are lower than expected and additionally to also explore the real-world management of patients with stage IIIa disease.


Spotlight report on molecular testing in advanced lung cancer

This spotlight audit is the first national study investigating the efficacy and outcomes of molecular testing in patients with advanced non-small-cell lung cancer (NSCLC) in England.


Mid-Year Report 2019

The mid-year report is designed to give trusts an opportunity to review their interim results before the full publication at the end of the year. This report covers the period Jan 2018 - June 2018 and is not publically available, but was sent directly to local lung cancer clinical leads.


Annual Report 2018 (Patient/Carer)

We have produced a patient-level booklet to help inform lung cancer patients, their families and their carers about the level of care they can expect. Working with the Roy Castle Lung Cancer Foundation we consulted lung cancer patients, carers and families to help us write this booklet, which showcases the results from our 2018 annual report.


Annual Report 2018

The National Lung Cancer Audit 2018 report demonstrates the key findings from the 14th annual audit for lung cancer patients diagnosed in 2017 in England, Wales, Guernsey and Jersey. The purpose of the audit is to review the quality of lung cancer care, to highlight areas for improvement and to reduce variation in practice.


Mid-Year Report 2018

The mid-year report is designed to give trusts an opportunity to review their interim results before the full publication at the end of the year. This report covers the period Jan 2017 - June 2017 and is is not publically available, but was sent directly to local lung cancer clinical leads.


Annual Report 2017 (Patient/Carer)

Our patient-level booklet helps inform lung cancer patients, their families and their carers about the level of care they can expect. We have worked closely with Roy Castle Lung Cancer Foundation, and patients, to create this booklet which showcases the results from our 2017 annual report.


Annual Report 2017

The National Lung Cancer Audit 2017 report demonstrates the key findings from the 13th annual audit for lung cancer patients diagnosed in 2016 in England, Wales and Guernsey. The purpose of the audit is to review the quality of lung cancer care, to highlight areas for improvement and to reduce variation in practice.


Mid-Year Report 2017

The mid-year report is designed to give trusts an opportunity to review their interim results before the full publication at the end of the year. This is the first report and covers the period July 2015 - June 2016 inclusive. Being the first such report it is not publically available, but was sent directly to local lung cancer clinical leads.


Annual Report 2016

The National Lung Cancer Audit report 2016 demonstrates the key findings from the 12th annual audit for lung cancer patients diagnosed in 2015 in England, Wales, Guernsey and Scotland. The purpose of the audit is to review the quality of lung cancer care, to highlight areas for improvement and to reduce variation in practice.


Annual Report 2016 (Patient/Carer)

We have produced our first patient-level booklet to help inform lung cancer patients, their families and their carers about the level of care they can expect. Working with the Roy Castle Lung Cancer Foundation we consulted lung cancer patients, their carers and their families to help us write this booklet, which showcases the results from our 2016 annual report.


Annual Report 2015

The NLCA annual report 2015 provides a summary of comparative audit data on the treatments and outcomes for lung cancer patients who were first seen in NHS secondary care in 2014.


Annual Report 2014

The NLCA annual report 2014 provides a summary of comparative audit data on the treatments and outcomes for lung cancer patients who were first seen in NHS secondary care in 2013.


Copyright © 2017 National Lung Cancer Audit